The use of clustered regularly interspaced short palindromic repeats (CRISPR) technology in developing novel treatments against infection diseases

• In: Novel antimicrobials in the pipeline and the use of computational medicinal chemistry in finding new antimicrobial agents on Monday, 1 September 2025, 13:00-14:00
• At: Copenhagen (Denmark) (2025)
• Type: Presentation
• By: GRøNDAHL, Christian
• Abstract:

  SNIPR BIOME develops CRISPR-based microbial gene therapies to address antimicrobial resistance, metabolic disorders, and immune conditions. SNIPR BIOM’s clinical pipeline includes SNIPR001-oral for preventing E. coli bloodstream infections in hematological cancer patients and SNIPR-IV for treating bloodstream infections. Notable achievements..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login